메뉴 건너뛰기




Volumn 58, Issue 12, 2014, Pages 1746-1752

The state of norovirus vaccines

Author keywords

norovirus; vaccine

Indexed keywords

NOROVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE; VIRUS VACCINE;

EID: 84901770358     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu120     Document Type: Article
Times cited : (71)

References (42)
  • 1
  • 3
    • 84869093870 scopus 로고    scopus 로고
    • The potential economic value of a human norovirus vaccine for the United States
    • Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. The potential economic value of a human norovirus vaccine for the United States. Vaccine 2012; 30:7097-104.
    • (2012) Vaccine , vol.30 , pp. 7097-7104
    • Bartsch, S.M.1    Lopman, B.A.2    Hall, A.J.3    Parashar, U.D.4    Lee, B.Y.5
  • 4
    • 84884815041 scopus 로고    scopus 로고
    • Proposal for a unified norovirus nomenclature and genotyping
    • Kroneman A, Vega E, Vennema H, et al. Proposal for a unified norovirus nomenclature and genotyping. Arch Virol 2013; 158: 2059-68.
    • (2013) Arch Virol , vol.158 , pp. 2059-2068
    • Kroneman, A.1    Vega, E.2    Vennema, H.3
  • 5
    • 84891541960 scopus 로고    scopus 로고
    • Genotypic and epidemiologic trends of norovirus outbreaks in the United States 2009-2013
    • Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinje J. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009-2013. J Clin Microbiol 2013; 52:147-55.
    • (2013) J Clin Microbiol , vol.52 , pp. 147-155
    • Vega, E.1    Barclay, L.2    Gregoricus, N.3    Shirley, S.H.4    Lee, D.5    Vinje, J.6
  • 6
    • 46049105910 scopus 로고    scopus 로고
    • Norwalk virus: How infectious is it?
    • Teunis PF, Moe CL, Liu P, et al. Norwalk virus: how infectious is it? J Med Virol 2008; 80:1468-76.
    • (2008) J Med Virol , vol.80 , pp. 1468-1476
    • Teunis, P.F.1    Moe, C.L.2    Liu, P.3
  • 7
    • 84903190763 scopus 로고    scopus 로고
    • Determination of the human infectious dose-50% for Norwalk virus
    • Atmar RL, Opekun AR, Gilger MA, et al. Determination of the human infectious dose-50% for Norwalk virus. J Infect Dis 2013.
    • (2013) J Infect Dis
    • Atmar, R.L.1    Opekun, A.R.2    Gilger, M.A.3
  • 8
    • 84883388614 scopus 로고    scopus 로고
    • A mouse model for human norovirus
    • Taube S, Kolawole AO, Hohne M, et al. A mouse model for human norovirus. MBio 2013; 4:4 e00450-13.
    • (2013) MBio , vol.4 , Issue.4
    • Taube, S.1    Kolawole, A.O.2    Hohne, M.3
  • 9
    • 0036889419 scopus 로고    scopus 로고
    • Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice
    • Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 2002; 76:12335-43.
    • (2002) J Virol , vol.76 , pp. 12335-12343
    • Harrington, P.R.1    Lindesmith, L.2    Yount, B.3    Moe, C.L.4    Baric, R.S.5
  • 10
    • 77957005956 scopus 로고    scopus 로고
    • Serological correlate of protection against norovirus-induced gastroenteritis
    • Reeck A, Kavanagh O, Estes MK, et al. Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis 2010; 202:1212-8.
    • (2010) J Infect Dis , vol.202 , pp. 1212-1218
    • Reeck, A.1    Kavanagh, O.2    Estes, M.K.3
  • 11
    • 36248961689 scopus 로고    scopus 로고
    • A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model
    • Souza M, Costantini V, Azevedo MS, Saif LJ. A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model. Vaccine 2007; 25:8448-59.
    • (2007) Vaccine , vol.25 , pp. 8448-8459
    • Souza, M.1    Costantini, V.2    Azevedo, M.S.3    Saif, L.J.4
  • 12
    • 78651063204 scopus 로고    scopus 로고
    • Chimpanzees as an animal model for human norovirus infection and vaccine development
    • Bok K, Parra GI, Mitra T, et al. Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci USA 2011; 108:325-30.
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 325-330
    • Bok, K.1    Parra, G.I.2    Mitra, T.3
  • 13
    • 33744505294 scopus 로고    scopus 로고
    • Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains
    • LoBue AD, Lindesmith L, Yount B, et al. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 2006; 24:5220-34.
    • (2006) Vaccine , vol.24 , pp. 5220-5234
    • Lobue, A.D.1    Lindesmith, L.2    Yount, B.3
  • 14
    • 39849097577 scopus 로고    scopus 로고
    • Mechanisms of GII.4 norovirus persistence in human populations
    • Lindesmith LC, Donaldson EF, LoBue AD, et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 2008; 5:e31.
    • (2008) PLoS Med , vol.5
    • Lindesmith, L.C.1    Donaldson, E.F.2    Lobue, A.D.3
  • 15
    • 84856943397 scopus 로고    scopus 로고
    • Monoclonal antibodybased antigenic mapping of norovirus GII.4-2002
    • Lindesmith LC, Debbink K, Swanstrom J, et al. Monoclonal antibodybased antigenic mapping of norovirus GII.4-2002. J Virol 2012; 86:873-83.
    • (2012) J Virol , vol.86 , pp. 873-883
    • Lindesmith, L.C.1    Debbink, K.2    Swanstrom, J.3
  • 16
    • 84856907832 scopus 로고    scopus 로고
    • Genetic mapping of a highly variable norovirus GII.4 blockade epitope: Potential role in escape from human herd immunity
    • Debbink K, Donaldson EF, Lindesmith LC, Baric RS. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity. J Virol 2012; 86:1214-26.
    • (2012) J Virol , vol.86 , pp. 1214-1226
    • Debbink, K.1    Donaldson, E.F.2    Lindesmith, L.C.3    Baric, R.S.4
  • 17
    • 70350380129 scopus 로고    scopus 로고
    • Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding
    • Allen DJ, Noad R, Samuel D, Gray JJ, Roy P, Iturriza-Gomara M. Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virol J 2009; 6:150.
    • (2009) Virol J , vol.6 , pp. 150
    • Allen, D.J.1    Noad, R.2    Samuel, D.3    Gray, J.J.4    Roy, P.5    Iturriza-Gomara, M.6
  • 19
    • 84874689661 scopus 로고    scopus 로고
    • Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes
    • Lindesmith LC, Costantini V, Swanstrom J, et al. Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes. J Virol 2013; 87:2803-13.
    • (2013) J Virol , vol.87 , pp. 2803-2813
    • Lindesmith, L.C.1    Costantini, V.2    Swanstrom, J.3
  • 20
    • 84888611899 scopus 로고    scopus 로고
    • Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity
    • Debbink K, Lindesmith LC, Donaldson EF, et al. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J Infect Dis 2013; 208:1877-87.
    • (2013) J Infect Dis , vol.208 , pp. 1877-1887
    • Debbink, K.1    Lindesmith, L.C.2    Donaldson, E.F.3
  • 21
    • 80052294511 scopus 로고    scopus 로고
    • Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period
    • Boon D, Mahar JE, Abente EJ, et al. Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period. J Virol 2011; 85:8656-66.
    • (2011) J Virol , vol.85 , pp. 8656-8666
    • Boon, D.1    Mahar, J.E.2    Abente, E.J.3
  • 22
    • 84891700334 scopus 로고    scopus 로고
    • Characterization of blockade antibody responses in GII.2. 1976 SMV infected subjects
    • Swanstrom J, Lindesmith LC, Donaldson EF, Yount B, Baric RS. Characterization of blockade antibody responses in GII.2.1976 SMV infected subjects. J Virol 2013; 88:829-37.
    • (2013) J Virol , vol.88 , pp. 829-837
    • Swanstrom, J.1    Lindesmith, L.C.2    Donaldson, E.F.3    Yount, B.4    Baric, R.S.5
  • 24
    • 55549118890 scopus 로고    scopus 로고
    • Deceptive imprinting and immune refocusing in vaccine design
    • Tobin GJ, Trujillo JD, Bushnell RV, et al. Deceptive imprinting and immune refocusing in vaccine design. Vaccine 2008; 26:6189-99.
    • (2008) Vaccine , vol.26 , pp. 6189-6199
    • Tobin, G.J.1    Trujillo, J.D.2    Bushnell, R.V.3
  • 25
    • 84860997673 scopus 로고    scopus 로고
    • Immunogenicity and specificity of norovirus consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations
    • Parra GI, Bok K, Taylor R, et al. Immunogenicity and specificity of norovirus consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations. Vaccine 2012; 30:3580-6.
    • (2012) Vaccine , vol.30 , pp. 3580-3586
    • Parra, G.I.1    Bok, K.2    Taylor, R.3
  • 26
    • 78650941306 scopus 로고    scopus 로고
    • Quadrivalent human papillomavirus (HPV) vaccine: A review of safety, efficacy, and pharmacoeconomics
    • Pomfret TC, Gagnon JM Jr., Gilchrist AT. Quadrivalent human papillomavirus (HPV) vaccine: A review of safety, efficacy, and pharmacoeconomics. J Clin Pharm Ther 2011; 36:1-9.
    • (2011) J Clin Pharm Ther , vol.36 , pp. 1-9
    • Pomfret, T.C.1    Gagnon Jr., J.M.2    Gilchrist, A.T.3
  • 27
    • 78649587261 scopus 로고    scopus 로고
    • Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibodysecreting cells that express homing receptors for mucosal and peripheral lymphoid tissues
    • El-Kamary SS, Pasetti MF, Mendelman PM, et al. Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibodysecreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis 2010; 202:1649-58.
    • (2010) J Infect Dis , vol.202 , pp. 1649-1658
    • El-Kamary, S.S.1    Pasetti, M.F.2    Mendelman, P.M.3
  • 28
    • 84862260185 scopus 로고    scopus 로고
    • Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers
    • Ramirez K,Wahid R, Richardson C, et al. Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers. Clin Immunol 2012; 144:98-108.
    • (2012) Clin Immunol , vol.144 , pp. 98-108
    • Ramirez, K.1    Wahid, R.2    Richardson, C.3
  • 29
    • 83155182848 scopus 로고    scopus 로고
    • Norovirus vaccine against experimental human Norwalk virus illness
    • Atmar RL, Bernstein DI, Harro CD, et al. Norovirus vaccine against experimental human Norwalk virus illness. N Engl J Med 2011; 365: 2178-87.
    • (2011) N Engl J Med , vol.365 , pp. 2178-2187
    • Atmar, R.L.1    Bernstein, D.I.2    Harro, C.D.3
  • 31
    • 84880786047 scopus 로고    scopus 로고
    • Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice
    • Tamminen K, Lappalainen S, Huhti L, Vesikari T, Blazevic V. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice. PLoS One 2013; 8:e70409.
    • (2013) PLoS One , vol.8
    • Tamminen, K.1    Lappalainen, S.2    Huhti, L.3    Vesikari, T.4    Blazevic, V.5
  • 33
    • 84876931013 scopus 로고    scopus 로고
    • Norovirus P particle efficiently elicits innate, humoral and cellular immunity
    • Fang H, TanM, Xia M,Wang L, Jiang X. Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS One 2013; 8: e63269.
    • (2013) PLoS One , vol.8
    • Fang, H.1    Tan, M.2    Xia, M.3    Wang, L.4    Jiang, X.5
  • 34
    • 84875592440 scopus 로고    scopus 로고
    • Polyvalent complexes for vaccine development
    • Wang L, Huang P, Fang H, et al. Polyvalent complexes for vaccine development. Biomaterials 2013; 34:4480-92.
    • (2013) Biomaterials , vol.34 , pp. 4480-4492
    • Wang, L.1    Huang, P.2    Fang, H.3
  • 35
    • 83055188637 scopus 로고    scopus 로고
    • A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles
    • Tamminen K, Huhti L, Koho T, et al. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles. Immunology 2012; 135:89-99.
    • (2012) Immunology , vol.135 , pp. 89-99
    • Tamminen, K.1    Huhti, L.2    Koho, T.3
  • 36
    • 84863675596 scopus 로고    scopus 로고
    • Immunogenetic mechanisms driving norovirus GII.4 antigenic variation
    • Lindesmith LC, Beltramello M, Donaldson EF, et al. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog 2012; 8:e1002705.
    • (2012) PLoS Pathog , vol.8
    • Lindesmith, L.C.1    Beltramello, M.2    Donaldson, E.F.3
  • 37
    • 70349912037 scopus 로고    scopus 로고
    • Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patients
    • Koo HL, DuPont HL. Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patients. Clin Infect Dis 2009; 49:1069-71.
    • (2009) Clin Infect Dis , vol.49 , pp. 1069-1071
    • Koo, H.L.1    Dupont, H.L.2
  • 38
    • 84869997744 scopus 로고    scopus 로고
    • Norovirus gastroenteritis in immunocompromised patients
    • Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 2012; 367:2126-32.
    • (2012) N Engl J Med , vol.367 , pp. 2126-2132
    • Bok, K.1    Green, K.Y.2
  • 40
    • 0038447242 scopus 로고    scopus 로고
    • Vaccinations for adult solidorgan transplant recipients: Current recommendations and protocols
    • Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solidorgan transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003; 16:357-64.
    • (2003) Clin Microbiol Rev , vol.16 , pp. 357-364
    • Duchini, A.1    Goss, J.A.2    Karpen, S.3    Pockros, P.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.